ABIM Hematology flashcards
ABIM Hematology · Build recall with a focused review session.
32 cards. Read the term and the definition here. The deck at the top of this page is optional.
- Restrictive transfusion threshold
- For most stable hospitalized adults, a hemoglobin trigger of 7 to 8 g/dL is noninferior to a liberal trigger and reduces exposure to donor blood and transfusion reactions.
- Platelet threshold for lumbar puncture
- Platelet transfusion is generally recommended to raise the count to at least 50,000/microL before lumbar puncture or major surgery to reduce bleeding risk.
- Irradiated blood products indication
- Irradiation prevents transfusion-associated graft-versus-host disease and is indicated for Hodgkin lymphoma, aplastic anemia, and intrauterine or neonatal transfusion, among other cellular immunodeficiencies.
- Traumatic tap correction
- When cerebrospinal fluid is blood-contaminated, subtract one white blood cell per 700 red blood cells from the counted white cells to estimate the true cell count.
- Ferritin in iron deficiency
- A serum ferritin below 30 ng/mL is diagnostic of iron deficiency; values of 30 to 100 ng/mL require transferrin saturation to distinguish deficiency from inflammation.
- Anemia of chronic disease pattern
- Low serum iron, low total iron-binding capacity, normal or elevated ferritin, and reduced transferrin saturation characterize anemia of inflammation, which is typically normocytic.
- CML molecular hallmark
- Chronic myeloid leukemia is defined by the t(9;22) translocation producing BCR-ABL1; tyrosine kinase inhibitors are first-line therapy and response is tracked by quantitative transcript levels.
- APL genetic defining lesion
- Acute promyelocytic leukemia carries t(15;17) forming PML-RARA; treatment uses all-trans retinoic acid plus arsenic trioxide with aggressive platelet and fibrinogen support.
- Myeloma-defining events
- Plasma cell myeloma can be diagnosed without CRAB features when clonal plasma cells exceed 60 percent, free light chain ratio exceeds 100, or more than one MRI lesion is present.
- Heparin-induced thrombocytopenia management
- Stop all heparin immediately and start a non-heparin anticoagulant such as argatroban, bivalirudin, or fondaparinux; platelet transfusions are generally avoided because of thrombosis risk.
- TTP diagnostic confirmation
- Thrombotic thrombocytopenic purpura is confirmed by ADAMTS13 activity below 10 percent; plasma exchange should begin urgently on clinical suspicion without waiting for the result.
- Acute chest syndrome therapy
- Sickle cell acute chest syndrome is treated with oxygen, antibiotics, bronchodilators, incentive spirometry, and transfusion to a hemoglobin near 10 g/dL, avoiding hyperviscosity.
- Transfusion reaction root cause
- Clerical error causing wrong-blood administration is the most common cause of acute hemolytic transfusion reactions, so bedside identity verification is the key preventive control.
- Anticoagulation reversal time metric
- Interval from intracranial hemorrhage recognition to reversal agent administration is a trackable quality measure reflecting protocol reliability and pharmacy readiness.
- Single-unit transfusion metric
- The proportion of red cell orders that are single-unit with reassessment is a standard audit measure of blood stewardship and is reported to the hospital transfusion committee.
- Trial enrollment as quality measure
- The fraction of eligible patients screened and enrolled in clinical trials benchmarks access to novel therapy and care delivery performance in malignant hematology.
- Chemotherapy consent elements
- Consent must cover treatment intent, expected benefit, common and serious toxicities, alternatives including no therapy, and effects on fertility before cytotoxic agents are given.
- Serious news conversation steps
- Prepare the setting, assess baseline understanding, deliver information in plain language, respond empathetically to emotion, and summarize agreed next steps.
- Goals-of-care documentation
- Documented discussion of patient values and prognosis is associated with less unwanted aggressive end-of-life care and earlier hospice referral in advanced hematologic malignancy.
- Interpreter use standard
- Professional interpretation is required for patients with limited English proficiency; minor children and untrained family members should not serve as medical interpreters.
- Hematology handoff essentials
- Handoffs must state anticoagulation status, recent transfusions, neutropenia and isolation precautions, pending crossmatches, and time-critical therapy windows.
- Sunshine Act reporting
- Federal law requires public reporting of transfers of value from industry to physicians, including consulting fees, speaking honoraria, meals, and gifts.
- Genetic confidentiality limits
- Disclosing a heritable hematologic diagnosis to at-risk relatives generally requires patient permission, balancing family benefit against the duty of confidentiality.
- Research equipoise principle
- Human subjects research requires institutional review board approval and informed consent, with genuine uncertainty about comparative benefit and minimization of risk.
- Record alteration prohibition
- Retroactively editing the medical record to reflect orders or care that did not occur is fraudulent and grounds for disciplinary action.
- Anticoagulation stewardship program
- Such programs standardize indication, agent choice, monitoring, and reversal protocols, reducing bleeding events and drug cost across an institution.
- Hospital transfusion committee role
- This committee oversees blood utilization, reaction reporting, and blood bank policy, and commonly promotes restrictive transfusion protocols to improve safety and reduce cost.
- Infusion center capacity planning
- Chair time, pharmacy turnaround, and immediate hypersensitivity response capability must be planned to avoid delays in chemotherapy administration and to manage reactions safely.
- Prior authorization delay metric
- Tracking time from oral targeted agent prescription to approval identifies specialty pharmacy bottlenecks that delay initiation of tyrosine kinase inhibitors and similar drugs.
- Sickle cell medical home model
- A dedicated hematologist, written individualized pain plan, and coordinated emergency department protocol reduce crisis visits and improve continuity for adults with sickle cell disease.
- FACT accreditation scope
- The Foundation for the Accreditation of Cellular Therapy accredits transplant and apheresis programs, verifying quality standards for stem cell collection, processing, and administration.
- Value-based hematology measures
- Payment models increasingly link reimbursement to emergency department use, readmissions, and adherence to oral anticoagulants or tyrosine kinase inhibitors.